{
    "Trade/Device Name(s)": [
        "Aptima Herpes Simplex Viruses 1 & 2 Assay"
    ],
    "Submitter Information": "Hologic, Inc.",
    "510(k) Number": "K162673",
    "Predicate Device Reference 510(k) Number(s)": [
        "K103798"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OQO"
    ],
    "Summary Letter Date": "May 16, 2017",
    "Summary Letter Received Date": "May 17, 2017",
    "Submission Date": "June 14, 2017",
    "Regulation Number(s)": [
        "21 CFR 866.3305"
    ],
    "Regulation Name(s)": [
        "Herpes simplex virus serological assays"
    ],
    "Analyte Class(es)": [
        "virology"
    ],
    "Analyte(s)": [
        "Herpes Simplex Virus Type 1 (HSV-1) mRNA",
        "Herpes Simplex Virus Type 2 (HSV-2) mRNA"
    ],
    "Specimen Type(s)": [
        "Clinician-collected swab specimens from anogenital skin lesions"
    ],
    "Specimen Container(s)": [
        "Aptima specimen transport medium (STM)",
        "Viral transport media (VTM) immediately diluted into STM"
    ],
    "Instrument(s)/Platform(s)": [
        "Panther system"
    ],
    "Method(s)/Technology(ies)": [
        "Nucleic acid amplification test (NAAT)",
        "Transcription-mediated amplification (TMA)",
        "Real-time detection",
        "Target capture",
        "Magnetic microparticle extraction",
        "Fluorescence-based detection"
    ],
    "Methodologies": [
        "Qualitative detection",
        "Real-time TMA",
        "Amplicon detection by fluorescent probes"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Control",
        "Reagent",
        "System",
        "Specimen collection device",
        "Transport medium"
    ],
    "Document Summary": "FDA 510(k) summary for Aptima Herpes Simplex Viruses 1 & 2 Assay utilizing real-time TMA on the Panther system for qualitative detection and differentiation of HSV-1 and HSV-2 mRNA in anogenital lesion swab specimens",
    "Indications for Use Summary": "Intended for qualitative detection and differentiation of HSV-1 and HSV-2 mRNA in clinician-collected swab specimens from anogenital skin lesions, aiding diagnosis of HSV-1 and/or HSV-2 infections in symptomatic male and female patients, for use on Panther system",
    "fda_folder": "Microbiology"
}